Michael Halstead Sells 22,869 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) President Michael Halstead sold 22,869 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $89.12, for a total value of $2,038,085.28. The sale was disclosed in a legal filing with the SEC, which is available at […]
More Stories
Speaker Johnson Says Budget Bill Act Won’t Trigger More Federal Spending
By Jack Phillips House Speaker Mike Johnson (R-La.) said that the budget bill endorsed by President Donald Trump that passed...
Messi’s Late Free Kick Goal Sparks Inter Miami to Rally for a 3–3 Tie Against Union
By The Associated Press CHESTER, Pa.—Lionel Messi gave Inter Miami a pep talk this week, exhorting his MLS team to...
Key Vote Puts Texas Closer to Displaying Ten Commandments in Classrooms
By Jacob Burg The Texas Legislature cleared a major vote on May 24 on a measure that would require the...
Amazon.com, Inc. (NASDAQ:AMZN) is Concorde Financial Corp’s 6th Largest Position
Concorde Financial Corp lifted its position in Amazon.com, Inc. (NASDAQ:AMZN) by 0.3% in the 4th quarter, HoldingsChannel reports. The firm...
Crow s Nest Holdings LP Decreases Stock Holdings in Amazon.com, Inc. (NASDAQ:AMZN)
Crow s Nest Holdings LP cut its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 19.1% during the fourth quarter, according to...
Amazon.com, Inc. (NASDAQ:AMZN) Shares Sold by Concentric Capital Strategies LP
Concentric Capital Strategies LP lowered its position in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 33.1% in the fourth quarter, according...